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The studies of quality of life (QoL) are becoming increasingly interesting in clinical setting because their findings have implications
for making decisions on resource allocation and health policies. The assessment of health-related QoL is especially directed to
patients with chronic illnesses that cause progressive deterioration and limitations, and consume the bulk of financial resources for
health. Among these chronic kidney disease and, more specifically the renal replacement therapy, is an important condition. Due
to the diagnostic and therapeutic advances, we see a gradual increase both in the number of the dialysis population and its age,
which leads to a growing interest in the study of these patients’ QoL, as evidenced by more than one thousand articles published
on this subject.
1. Definition of Quality of Life
Quality of life is a difficult variable to define. We dis-
tinguish two basic characteristics in the concept of QoL:
subjectivity and multidimensionality. Subjectivity should be
distinguished because the QoL is a unique perception for
each individual, which reflects the patient’s self-assessment
about their own health, defined by medical and nonmedical
aspects of their lives. In fact, patients use the possible negative
impact or treatment side effects for the evaluation of any
medical intervention. Therefore, the success or failure of a
medical intervention is the QoL acquired or recovered after
it, in spite of success or technical failure of the procedure
itself. Moreover, QoL is a multidimensional concept that
comprised not only aspects directly related to health but also
other nonmedical aspects, but the autonomy, the retention
of employment, the impact on family relationships, the
economic resources, and many other life circumstances are
connected as well.
Many definitions have been proposed for an individual-
ized, dynamic, and multifaceted concept. Thus, it has been
defined as “the value assigned by an individual per year of
life, modified by the social disadvantage, the perception, the
functional status, or deficiencies due to illness, treatment or
accident”, while the WHO definies it as: “the perception that
individual makes about his position in life, within its cultural
context and value system, and related to its goals and vital
objectives.” Perhaps one of the rough and clear definitions
referred to QoL is “the measure resulted from the physical,
mental, and social well-being, such as is perceived by each
individual.” The medical and nonmedical factors are both
related: the illness, as well as having an impact on the physical
area of a person, has impact on the personal psychological
state and his social relations. So we use the term health
related quality of life, which could have been formally defined
as “The extent to which one’s usual or expected physical,
emotional and social well-being is affected by a medical
condition or its treatment.” The concept of health related-
quality of life (HRQOL) covers the impact of the disease or
medical actions on the physical symptoms, functional status,
and mental and social functioning [1–3].
2 International Journal of Nephrology
2. Quality of Life and Chronic
Kidney Disease (CKD)
Chronic kidney disease (CKD) has a great impact on
HRQOL [4–7]. Symptoms appear and induce substantial
changes in lifestyle from the early stages of the disease
to the substitution treatment such as hemodialysis (HD),
peritoneal dialysis (PD), or renal transplantation (RT). CKD
is invariably associated with decreased HRQOL, and there
is a correlation between the magnitude of the effect on
HRQOL and glomerular filtration rate. The most affected
HRQOL areas are work and leisure, family life, and sleep and
rest. Although an adequate treatment of patients during the
predialysis stage may slow the progression of CKD and that is
recognized as an important factor ofmorbidity andmortality
(and therefore of HRQOL) of kidney patients, the start
of dialysis treatment is the patients’ turning point in their
concept of quality of life. They go from a situation of “normal
life” (often idealized) to a state of “mortal danger” or “life
without health” that requires dialysis to stay alive. There are
several aspects that affected patients will feel altered.
(i) The Well-Being. The repetition and frequency of dialysis
procedure constantly reminds one of the disease, favouring
self-analysis that exaggerates physiological phenomena. On
the other hand, decreased sexual desire and activity (present
in up to 50% of patients) are experienced as a sign of
advanced age and interfere with relationships. Finally, dietary
restrictions are perceived (and therefore often ignored) as the
deprivation of the last “pleasure” that patients keep.
(ii) Body Image. Issues like skin colour, body odour, loss of
urinary function, sexual impotence, internal arteriovenous
fistula or peritoneal catheter presence, scars, or abdominal
distension help patients to perceive their bodies negatively
and with inferiority feeling. And these feelings will limit the
social and family relationships, encouraging introversion.
(iii) Autonomy. The frequency of dialysis (either HD or
exchange sessions in PD) interferes and limits the lifestyle
of patients. On the other hand, inferiority feelings facilitate
physical deterioration, passivity, neglect, and dependency,
often enhanced by the good-intentioned help from patient’s
family and social environment.
(iv) The Mental Attitude. Anxiety is always in the back-
ground due to daily contact with the disease and the risk
of death. And that anxiety leads to distress, somatisation,
obsessive attitudes, depression, aggression, and so forth.
Today, due to scientific and medical advances, patients
survive with problems that were deadly time ago, but
this survival is often associated with various degrees of
disability, causing dependence and a greater need of both
medical and social care. The progressive aging of the dialysis
population and greater comorbidity is a fact, and the close
relationship between HRQOL and mortality score confirms
the importance of including quality-of-life markers in the
clinical management of patients. Moreover, now patients not
only have an expectation to survive but also expect to achieve
a certain level of well-being.
3. Measuring Instruments for
HRQOL Assessment
As most of the components of HRQOL cannot be observed
directly, to quantify this so broad and “confused” term
we need measuring instruments such as HRQOL ques-
tionnaires. These instruments involve both subjective and
objective measures. The subjective assessments involve any
aspect of patients’ health status that comes directly from the
patient without interpretation of the response by a health
care provider. The objective assessment of patient status is
needed to evaluate the impact of health on quality of life
and formulate clinical intervention strategies [1, 3, 4, 7]. The
dimensions usually measured by HRQOL questionnaires are
(i) physical function: mobility, self-care, and work,
(ii) emotional Function: well-being, satisfaction, depres-
sion, and anxiety,
(iii) social function: social support, family, and social
relationships,
(iv) cognitive function: ability to reason, think, concen-
trate, and remember,
(v) other general or specific symptoms: sleep distur-
bance, sexual function, energy/vitality, pain, life sat-
isfaction, body image, and so forth.
HRQOL questionnaires were designed and validated for
specific populations and cultures, and therefore they need
to be adapted to the language and culture in which it will
be used, preserving the semantic content and thus leading to
the equivalence between the two populations. This process
of adaptation must be made according to scientific standards
and has a complex but validated methodology. Therefore,
the use of free translations of the original questionnaire is
considered improper. It is often preferable to use a HRQOL
questionnaire adapted to a new one, because in this way not
only studies can be made to compare large groups, but also
this use will be faster and cheaper.
HRQOL instruments are used for three main purposes:
to discriminate between patients with better and worse
HRQOL at one time, to assess how much the quality of
life has changed between two different time points, and to
predict future HRQOL from a current measurement. For
accomplishing these purposes, the questionnaires must meet
certain requirements to ensure valid and reliable clinical data
[1, 3]. These requirements are the following.
(i) Viability. The best questionnaire will be useless if its
implementation is difficult, costly, and complex for both
patient and health professionals. This is why aspects such as
simplicity, brevity and clarity of the questions, and ease of
completion and correction must be valued.
(ii) Reliability. It indicates the degree to which a measure-
ment is free from random error and refers to the degree
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Physical activity equivalent points
Normal activity with minor symptoms …………………………………………….…90 
Normal activity with some effort ……………………………………………………  80 
Able to care but unable to do normal activities or active work …………………..….. 70 
Requires occasional attention, but is able of most of their own needs ………………  60
Need intensive and frequent medical care ………………………………………........ 50 
Unable, needs special help and assistance……………………………………………  40 
Totally incapable, requires hospitalization and active supportive therapy …………..  30 
Very sick, active supportive treatment needed ………………………………………  20 
Irreversible, dying …………………………………………………………………… 10 
Dead  ………………………………………………………………………………… 0
Normal, no evidence of disease ………………………………………………………100 
Figure 1: Karnofsky scale physical.
to which they can reproduce the results obtained under
constant conditions, even in an extended series of repeated
assessments. In addition, it refers to the homogeneity of
items comprising the questionnaire.
(iii) Coverage. The questionnaire should include all basic
dimensions that are important to members of the patient
population and susceptible to being affected, positively or
negatively, by interventions.
(iv) Validity. It measures only what they claim to measure.
(v) Sensitivity to Change. It shows the ability to detect and
reflect true changes or differences in patient health.
(vi) Clinical Significance. The definition of “minimal clinical
important difference”, which is the rate of change in score
of HRQOL questionnaire that should make the medical
treatment, will be implanted.
(vii) Reproducibility. It shows stability over time, with little
variation between intra- and interobservations.
(viii) Internal Consistency. All questions in one dimension
(physical, emotional, etc.) measure the same concept.
The HRQOL questionnaires can be generic or disease-
specific. Generics questionnaires can be broadly used in
different diseases and patient groups because they cover a
wide range of dimensions of HRQOL, while the disease-
specific questionnaires are designed for a population or a
disease including the most relevant dimensions for patients
affected by a particular condition. Disease-specific instru-
ments are more sensitive to clinical changes but do not
allow HRQOL comparisons among patients with different
pathologies. Themost comprehensive assessment of HRQOL
includes an assessment of both generic and disease-specific
questionnaires [8].
4. HRQOLMeasurement
Instruments in Nephrology
The Generic questionnaires most commonly used in nephrol-
ogy are the following.
(i) The Short Form-36 (SF-36). It is a short form of
HRQoL scoring system with 36 items forming eight
multi-item scale measuring physical functioning, role
of physical, bodily pain, general health, vitality, social
functioning, and role of emotions and emotional
health [7, 9]. It is one of the most commonly used
HRQOL questionnaires used in CKD patients with or
without maintenance dialysis therapy.
(ii) Nottinghan Health Profile. It consists of 38 items to
measur 6 dimensions and is widely used because of
its simplicity [10].
(iii) Sickness Impact Profile (SIP). It comprises 136 items
to measure 12 dimensions [11].
(iv) The Karnofsky Scale. It was initially designed for
cancer patients and is an ordinal scale ranging from a
score 100 (normal state) to 0 (dead) which focuses
exclusively on physical functioning and on role of
limitations imposed by physical health [12] (see
Figure 1).
(v) COOP-WONKA Charts [13] (see Figure 2).
(vi) The Squedule for Evaluation of Individual Quality of
Life (SEIQOL). It is an established instrument that
seeks to asses QoL on the basis of the domains that
patients feel important [5, 7].
The specific questionnaires mostly used for kidney pa-
tients are the following.
(i) Kidney Disease Quality of Life Questionnaire (KDQOL).
It includes the SF-36 as the generic core, supplemented with
multi-item scales targeted at particular concern of patients
with CKD and on dialysis [7].
4 International Journal of Nephrology
Physical fitness
During the past 4 weeks
What was the hardest physical activity you could do for at least
2 minutes? 
Very heavy (for example)
- Run, at a fast pace
- Carry a heavy load upstairs or uphill
1
Heavy (for example)
- Jog, at a slow pace
- Climb stairs or a hill moderate pace 2
Moderate (for example)
- Walk, medium pace
- Carry light load level ground  
3
Light (for example)
- Walk, medium pace
- Carry light load level ground 
4
Very light (for example)
-Walk, at a slow pace or not able to walk
- Wash dishes
5
(a)
Feelings
During the past 4 weeks
To what extent have you been bothered by emotional
 problems such as feeling anxious, depressed, irritable 
or downhearted and sad?
Not at all
1
Slightly
2
Moderately
3
Quite a bit
4
Extremely
5
(b)
Daily activities
How difficult has it been for you to do of your usual 
activities or tasks, both inside and outside the house
because of your physical and emotional health? 
No difficulty at all 
1
A little bit of difficulty
2
Some difficulty
3
Much difficulty
4
Could not do
5
(c)
Social activities
During the past 4 weeks
Has your physical and emotional health limited your 
social activities with family, friends, neighbors, or groups?
Not at all
1
Slightly
2
Moderately
3
Quite a bit
4
Extremely
5
(d)
Figure 2: Continued.
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Change in health 
How would you rate your overall health now compared to 
4 weeks ago? 
Much better 1
A little better 2
About the same 3
A little worse 4
Much worse 5
(e)
Overall health
During the past 4 weeks
How would you rate your health in general?
Excellent
1
Very good
2
Good
3
Fair
4
Poor
5
(f)
Social support
During the past 4 weeks
Was someone available to help you if you needed and wanted help? For example if you
- felt very nervous, lonely, or blue
- got sick and had to stay in bed
- needed someone to talk to
- needed help with daily chores
- needed help just taking care of yourself  
Yes, as much as I wanted
1
Yes, quite a bit
2
Yes, some
3
Yes, a little
4
No, not at all
5
(g)
Pain
During the past 4 weeks
How much bodily pain have you generally had?
No pain
1
Yes, mild pain
2
Mild pain
3
Moderate pain
4
Severe pain
5
(h)
Figure 2: Continued.
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Quality of life
How have things been going for 
you during the past 4 weeks?
Very well:
could hardly be better
Pretty good
Pretty bad
Good and bad parts
about equal
Very bad:
could hardly be worse
1
2
3
4
5
(i)
Figure 2: Example of COOP/WONCA charts.
(ii) KDQOL-SF. It is a short form of KDQOL that consists
of the SF-36 plus a small set of 43 kidney-disease-targeted
items. It is the most commonly used.
(iii) Parfrey Test. It is a Specific test for patients on hemodial-
ysis and consists of 24 items distributed in two dimensions
(physical and emotional) [14].
There is not a specific questionnaire for patients on peri-
toneal dialysis.
5. HRQOL Studies and CKD
Early HRQoL studies conducted in CKD were published for
more than 20 years. Initially served to analyze the quality of
life of uremic patients compared with the general population,
showing in general lower scores in patients with CKD.
The following studies focused on comparing patients on
dialysis (any modality) and renal transplant, confirming a
better HRQOL in the last, coming to score similar as to
that of healthy populations. Most recent studies focus on
the hemodialysis population (largest) and those technique
and treatment factors that may influence morbidity and
mortality of patients.
So, KDQOL-SF has been used in HEMO and DOPPS
studies [15, 16]. TheHEMO study is randomizedmulticenter
prospective one, which studies the effect of CKD and
hemodialysis treatment on quality of life. The DOPPS (Dial-
ysis Outcomes and Practice Patterns Study) is a prospective,
multicenter study over a population of 10,000 patients that
found an independent relationship between the physical
dimension score of the SF-36 and hospitalization and mor-
tality; this relationship was not shown in the mental dimen-
sion. The opposite results, however, were observed in the
Spanish multicenter study, CALDIVIA, in which the mental
dimension was the score that predicted hospitalization and
mortality. The CHOICE Health Experience Questionnaire,
which has 5 ESRD-specific domains (diet, freedom, body
image, dialysis access, and symptoms) added to 8 generic
domains in the SF-36 and 8 additional generic domains, is
an instrument for measuring heath-related quality of life for
patients with ESRD designed to evaluate the effectiveness of
alternative dialysis modalities and prescriptions [17].
In general, most of HRQoL studies are observational
and do not appreciate the change in HRQOL scores after
interventions to improve health status.
6. HRQOL Studies and Peritoneal Dialysis
There are few, and most of them are comparative with
haemodialysis, so many of the differences between the two
populations reflect different policies for inclusion of patients
on peritoneal dialysis [18–21]. Patients who are on peritoneal
dialysis for the first time and by own choice tend to
have better clinical state (physical, emotional, autonomous,
social) maintain longer residual clearance, with the clinical
implications that it supposes. Fewer jobs compare manual
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and automated peritoneal dialysis. Although a priori the
automated mode (DPA) should have better HRQOL scores
both for the technical characteristics and for the patient’s
autonomy, this has not been confirmed in recent reviews in
which automated peritoneal dialysis has not been shown to
provide a relevant improvement in HRQOL compared to
manual mode, except in a greater availability of free time
[22–25].
Among the studies comparing different modalities of
dialysis therapy, we highlight the NECOSAD Study Group’s
[20] that analyzes the effect of starting dialysis with
haemodialysis or peritoneal dialysis modalities on survival
adjusted for quality of life, the meta-analysis of Cameron
et al. [21] that studies HRQOL of patients undergoing
different types of renal replacement therapy and the Diaz-
Buxo’s [19] report analyzing quality of life in hemodialysis
and peritoneal dialysis patients.
Comparing the two types of peritoneal dialysis, we can
outline the Van Biesen et al.’s [22] serie and the recent one of
Michels et al. that did not find significant differences between
the HRQOL in manual or automated peritoneal dialysis, as
will as the DeWit et al.’s [23] report which shows only a slight
improvement in mental health in patients on automated
peritoneal dialysis and the Bro’s study in which patients on
APD had improved social and family issues and worse scores
in the section on sleep.
7. Practical Applications of the Study of HRQOL
for PD Patients
From the various studies about HRQoL conducted in dif-
ferent populations of kidney patients, factors with a proven
to relationship and affecting the quality of life were iden-
tified. Thus, it is shown that the improvement of various
parameters of the quality of life of patients was achieved with
a better hematocrit. Other factors whose relationship has
been confirmed are the predialysis control, the tolerance to
dialysis procedure, the psychological situation, and finally sex
and age. Treatment of depression, pain, and sleep disorders
and changes in the regimen of dialysis therapy have been
suggested to have positive effects on HRQOL.
It is obvious that it would be much easier for everyone
to translate the results of therapeutic measures of HRQOL to
specific therapeutic manoeuvres, but unfortunately, and due
to the peculiarities of the concept of quality of life, that is not
possible. Many times, the subjective factors, derived or not
from actual physical situations, determine the self-concept
of quality of life of patients. That is why the results of the
questionnaires should be analyzed carefully and thoroughly,
dedicating to the discussion with the patient the necessary
time to carry out actions aimed at improving the deficient
aspects. A recent paper focuses on this subject suggesting that
these tests could be applied as a nurse-led case management
programme [26].
The measurable parameters (hematocrit, KTV, albumin,
etc.) are not always the only ones on which we must depend,
and responses to questionnaires of HRQOL can focus on
what is more important for the patients. Here are some
simple measures applicable to peritoneal dialysis that can
benefit many aspects assessed with HRQOL questionnaires.
(i) Body Image. A lower insertion of a shorter peritoneal
catheter makes it easily concealable even under swimwear;
reducing the exchange volume as much as adequacy permits;
avoiding the premature loss of residual renal function; giving
instructions about skin care and oral hygiene.
(ii) Physical State. Controlling the anaemic status, the nutri-
tion, and the possible associated diseases (digestive, vascular,
cardiac); starting dialysis sequentially.
(iii) Work and Social Life. Accommodating as much as
possible the schedules of peritoneal exchanges to the usual
scheme of patient’s life; offering automated peritoneal
dialysis; facilitating alternative schedules of treatment or
guidelines for the various social contingencies that may arise.
(iv)Mobility andHospital Dependence. Minimizing hospital-
ization, spacing periodic controls (telemedicine), facilitating
telephone contact, and cooperating with home care services.
(v) The Self-Care. Avoiding overload the patients with a
“hospitalary method” for their daily care that will constantly
remind them of their illness, but without letting them
feel abandoned; seeking alternatives to a possible lack
of infrastructure to perform the technique: involving the
family only just to discourage the feeling of dependency or
disability; using the minimum number of exchanges that
adequacy permits.
(vi) The Emotional State. Maintaining a fluid dialogue
between caregiver and patient; discussing all aspects of
nephrology treatment; resolving doubts and problems, look-
ing for extrarenal situations that may interfere with the
perception of well-being; stopping the progress of any
depressive state.
(vii) Diet. Reducing as much as possible the diet restrictions
(“a little bit of everything, a lot of anything”) andmaking that
patient see the reason for the limitations indicated; giving
menu suggestions, dietary supplements where necessary, or
oral moisturizers to reduce the thirst sensation.
(viii) Sex, Sleep, and Pain. Asking patients directly and
openly about these issues and trying to alleviate them (and
not considering them as “inevitable disease’s consequences”).
8. Final Comments
After almost 20 years from implementation, HRQOL ques-
tionnaires are not used routinely, perhaps because its
usefulness is not known, not only in the field of research
(analysis after pharmacological or therapeutic interventions,
cost-effectiveness assessment of new technologies) but also
in the clinical setting (descriptive analysis of population, like
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a parameter of clinical quality). K-DOQI Guidelines 2000
recommend, in form of opinion, the periodic assessment
of HRQOL of patients in any of the stages of CKD and in
the specific population on peritoneal dialysis. Instruments
recommended are the SF-36, KDQOL, and COOP-WOKA
sheets, advising to always use the same one to improve data
analysis over time.
For practical purposes, and while experience is not
acquired in handling and interpretation, the Karnofsky scale
and CCOP-WONCA sheets are easily applicable instruments:
the time spent in filling them is little, they are attractive to
patients and easy to evaluate, and their use lights clinical
aspects that otherwise would be ignored.
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